Bora Pharmaceuticals Co. Ltd (BORAY)

$3.85 -0.65 (-14.44%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, inclu...

Phone: 886 2 27901555
Fax: 886 2 2790 6595
Address:
No. 2, Ruiguang Road, 6th Floor Alley 36, Lane 26 Neihu District, Taipei, Taiwan
prismmarketview
prismmarketview Feb. 23 at 7:53 PM
Bora Pharmaceuticals (OTCQX: $BORAY) is getting a visibility boost after renewing a five-year, 250 million‑dollar global manufacturing deal with GSK (NYSE: $GSK), locking in long-term CDMO revenue tied to key HIV and malaria medicines. https://prismmarketview.com/bora-pharmaceuticals-secures-250-million-manufacturing-deal-with-gsk-expanding-long-term-revenue-visibility/
0 · Reply
Latest News on BORAY
No data available.
prismmarketview
prismmarketview Feb. 23 at 7:53 PM
Bora Pharmaceuticals (OTCQX: $BORAY) is getting a visibility boost after renewing a five-year, 250 million‑dollar global manufacturing deal with GSK (NYSE: $GSK), locking in long-term CDMO revenue tied to key HIV and malaria medicines. https://prismmarketview.com/bora-pharmaceuticals-secures-250-million-manufacturing-deal-with-gsk-expanding-long-term-revenue-visibility/
0 · Reply